Literature DB >> 21995565

Applying the uncertainty principle to immunology.

Ena Wang1, Francesco M Marincola.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21995565      PMCID： PMC3517186          DOI： 10.2217/imt.11.125

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  19 in total

Review 1.  Macrophages in cancer and infectious diseases: the 'good' and the 'bad'.

Authors:  Chiara Porta; Elena Riboldi; Maria Grazia Totaro; Laura Strauss; Antonio Sica; Alberto Mantovani
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

2.  Role of cytotoxic CD4+ T cells in cancer immunotherapy.

Authors:  Margherita Gigante; Elena Ranieri
Journal:  Immunotherapy       Date:  2010-09       Impact factor: 4.196

Review 3.  The immunologic constant of rejection.

Authors:  Ena Wang; Andrea Worschech; Francesco M Marincola
Journal:  Trends Immunol       Date:  2008-05-03       Impact factor: 16.687

Review 4.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

5.  Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.

Authors:  Pierpaolo Correale; Maria Saveria Rotundo; Maria Teresa Del Vecchio; Cinzia Remondo; Cristina Migali; Chiara Ginanneschi; Kwong Y Tsang; Antonella Licchetta; Susanna Mannucci; Lucia Loiacono; Pierfrancesco Tassone; Guido Francini; Pierosandro Tagliaferri
Journal:  J Immunother       Date:  2010-05       Impact factor: 4.456

6.  Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Authors:  Purevdorj B Olkhanud; Bazarragchaa Damdinsuren; Monica Bodogai; Ronald E Gress; Ranjan Sen; Katarzyna Wejksza; Enkhzol Malchinkhuu; Robert P Wersto; Arya Biragyn
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

Review 7.  Chronic inflammation and immunologic-based constraints in malignant disease.

Authors:  Devin B Lowe; Walter J Storkus
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

Review 8.  Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.

Authors:  Tetsuro Sasada; Shigetaka Suekane
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

Review 9.  Tumour immunity: effector response to tumour and role of the microenvironment.

Authors:  Alberto Mantovani; Pedro Romero; A Karolina Palucka; Francesco M Marincola
Journal:  Lancet       Date:  2008-02-13       Impact factor: 79.321

10.  Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.

Authors:  Matin M Imanguli; William D Swaim; Stacy C League; Ronald E Gress; Steven Z Pavletic; Frances T Hakim
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.